Toxgene Ar Biolabs Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.09 Cr
- Company Age 2 Year, 6 Months
- Open Charges ₹ 4.13 Cr
About Toxgene Ar Biolabs
Toxgene Ar Biolabs Private Limited (TABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 14 July 2022 (Two years and six months 20 days old ). Its registered office is in Chittoor, Andhra Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.09 Cr.
The company currently has active open charges totaling ₹4.13 Cr.
Rahamthulla Syed and Anish Veera serve as directors at the Company.
Company Details
- Location
Chittoor, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85100AP2022PTC122260
- Company No.
122260
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 2022
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Toxgene Ar Biolabs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahamthulla Syed  | Director | 14-Jul-2022 | Current |
| Anish Veera | Director | 14-Jul-2022 | Current |
Financial Performance of Toxgene Ar Biolabs.
Enhance accessibility to Toxgene Ar Biolabs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Toxgene Ar Biolabs?
Unlock access to Toxgene Ar Biolabs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pathgene Health Care Private LimitedRahamthulla Syed is a mutual person
Urantiis Pharmaceuticals Private LimitedRahamthulla Syed is a mutual person
- Tirupati Electronics Manufacturing Cluster Limited
Rahamthulla Syed is a mutual person
Charges (Loans)
₹4.13 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 4.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Nov 2022 | Bank Of India | ₹4.13 Cr | Open |
How Many Employees Work at Toxgene Ar Biolabs?
Toxgene Ar Biolabs has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Toxgene Ar Biolabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Toxgene Ar Biolabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.